Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 51 | TGTXTG TherapeuticsHealthcare | $56.19 | +0.8% | +77.0% | −4.9% | $8.60B |
| 52 | IARTIntegra LifeSciencesHealthcare | $16.27 | −3.4% | +76.8% | −18.0% | $1.27B |
| 53 | RGENRepligenHealthcare | $194.09 | +6.6% | +76.3% | 0.0% | $10.95B |
| 54 | MANEVeradermics, IncorporatedHealthcare | $115.00 | +13.0% | +75.5% | −11.4% | $4.80B |
| 55 | BLLNBillionToOneHealthcare | $121.72 | +27.9% | +75.0% | −18.8% | $5.74B |
| 56 | INBXInhibrx BiosciencesHealthcare | $101.71 | −17.9% | +74.2% | −28.3% | $1.50B |
| 57 | REPLReplimune GroupHealthcare | $12.56 | −19.5% | +74.0% | −21.4% | $1.18B |
| 58 | AMRXAmneal PharmaceuticalsHealthcare | $20.50 | +13.8% | +73.0% | 0.0% | $7.14B |
| 59 | CONConcentra Group Holdings ParentHealthcare | $35.36 | +1.9% | +67.4% | −2.8% | $4.51B |
| 60 | SEPNSepternaHealthcare | $39.74 | −1.8% | +66.5% | −17.5% | $1.85B |
| 61 | KNSAKiniksa Pharmaceuticals InternationalHealthcare | $76.10 | −4.6% | +66.3% | −6.0% | $5.94B |
| 62 | OMDAOmada HealthHealthcare | $19.39 | −20.1% | +63.6% | −27.6% | $1.19B |
| 63 | LGNDLigand PharmaceuticalsHealthcare | $314.10 | +10.4% | +60.7% | −2.6% | $6.26B |
| 64 | NRIXNurix TherapeuticsHealthcare | $23.67 | −11.9% | +60.4% | −14.8% | $2.46B |
| 65 | AAgilent TechnologiesHealthcare | $175.21 | +11.1% | +58.9% | 0.0% | $49.40B |
| 66 | LBRXLB PharmaceuticalsHealthcare | $37.89 | −20.9% | +58.9% | −23.4% | $1.22B |
| 67 | BHVNBiohavenHealthcare | $13.27 | −17.7% | +58.5% | −26.7% | $2.00B |
| 68 | PRGOPERRIGOHealthcare | $15.10 | +5.1% | +58.4% | −32.9% | $2.10B |
| 69 | UFPTUFP TechnologiesHealthcare | $299.22 | −0.2% | +57.9% | −10.6% | $2.32B |
| 70 | NEOGNeogenHealthcare | $13.72 | +16.9% | +57.7% | −1.9% | $2.99B |
| 71 | WSTWest Pharmaceutical ServicesHealthcare | $375.65 | +8.5% | +54.4% | −0.1% | $26.44B |
| 72 | GKOSGlaukosHealthcare | $158.56 | −12.8% | +53.7% | −16.3% | $9.35B |
| 73 | IMAXImaxHealthcare | $56.13 | +8.1% | +53.6% | 0.0% | $3.08B |
| 74 | WATWatersHealthcare | $442.94 | +5.1% | +53.2% | 0.0% | $43.52B |
| 75 | CSTLCastle BiosciencesHealthcare | $35.93 | +4.9% | +52.7% | −16.5% | $1.10B |
| 76 | ZBIOZenas BioPharmaHealthcare | $27.55 | −15.5% | +51.3% | −36.2% | $1.80B |
| 77 | HRMYHarmony Biosciences HoldingsHealthcare | $40.01 | +0.4% | +50.8% | −6.6% | $2.33B |
| 78 | VCYTVeracyteHealthcare | $45.23 | 0.0% | +50.7% | −25.2% | $3.64B |
| 79 | WGSGeneDx HoldingsHealthcare | $85.93 | −3.7% | +50.5% | −48.7% | $2.56B |
| 80 | HIMSHims & Hers HealthHealthcare | $28.78 | −9.1% | +48.5% | −54.1% | $6.71B |
| 81 | ITGRInteger HoldingsHealthcare | $126.38 | +0.9% | +48.1% | −0.1% | $4.30B |
| 82 | PGNYProgynyHealthcare | $25.52 | −1.3% | +47.8% | −21.1% | $1.96B |
| 83 | BAXBaxter InternationalHealthcare | $23.49 | −9.4% | +47.1% | −17.1% | $12.14B |
| 84 | MGTXMeiraGTx HoldingsHealthcare | $11.11 | −21.4% | +45.8% | −25.8% | $1.07B |
| 85 | KMTSKestra Medical TechnologiesHealthcare | $28.13 | +9.0% | +44.6% | −0.8% | $1.68B |
| 86 | NVCRNovoCure LimitedHealthcare | $15.83 | −12.0% | +44.3% | −20.8% | $1.84B |
| 87 | AMPHAmphastar PharmaceuticalsHealthcare | $27.39 | +25.2% | +44.1% | −6.8% | $1.17B |
| 88 | PTGXProtagonist TherapeuticsHealthcare | $142.44 | −4.7% | +43.9% | −10.2% | $9.22B |
| 89 | KYMRKymera TherapeuticsHealthcare | $112.00 | −6.8% | +43.3% | −12.0% | $9.31B |
| 90 | SOLVSolventumHealthcare | $89.54 | −1.5% | +42.7% | −3.1% | $15.24B |
| 91 | TECHBio-TechneHealthcare | $72.51 | +0.1% | +42.3% | −0.1% | $11.37B |
| 92 | BIOBio-Rad LaboratoriesHealthcare | $377.69 | −3.1% | +42.3% | −3.2% | $10.10B |
| 93 | PACSPACS GroupHealthcare | $43.06 | −2.7% | +40.8% | −11.1% | $6.82B |
| 94 | EXELExelixisHealthcare | $58.37 | +5.6% | +40.5% | −1.3% | $14.46B |
| 95 | SHCSotera HealthHealthcare | $18.45 | −5.3% | +40.5% | −5.7% | $5.27B |
| 96 | NHCNational HealthcareHealthcare | $225.97 | +1.7% | +40.3% | −4.6% | $3.54B |
| 97 | VTRSViatrisHealthcare | $18.27 | +8.2% | +40.0% | 0.0% | $20.98B |
| 98 | IMVTImmunovantHealthcare | $33.49 | −23.6% | +39.7% | −25.5% | $6.92B |
| 99 | INSPInspire Medical SystemsHealthcare | $70.00 | +15.1% | +39.6% | −51.4% | $2.02B |
| 100 | CHEChemedHealthcare | $514.30 | −1.1% | +39.5% | −7.0% | $6.72B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.